Vinicius Esteves

Vinicius Esteves

Auto-generated profile, based on publicly available information

Vinicius Esteves

Rede D’Or São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2016 in JAMA
Verified
Journal Article
Open access
PDF file
ARAnder Regueiro
Ander Regueiro
ALAxel Linke
Axel Linke
Azeem LatibAzeem Latib
Azeem Latib
NINikolaj Ihlemann
Nikolaj Ihlemann
MUMarina Urena
Marina Urena
JRJosep Rodés-Cabau
Josep Rodés-Cabau
Infective endocarditis following surgical valve replacement occurs in 1% to 6% of patients and is associated with high morbidity and mortality.1 Transcatheter aortic valve replacement (TAVR) has emerged as a therapeutic option for patients with aortic stenosis who are considered to be at high or prohibitive surgical risk.2 The rate of infective endocarditis within the year following TAVR has been reported to be 1.5%, ranging from 0.5% to 3.1%,3,4 similar to infective endocarditis rates after surgical valve replacement.5,6 Greater exposure to health care procedures, older age, and a considerable amount of foreign material (eg, stent struts) of the transcatheter valve prostheses may have contributed to increase the risk of infective endocarditis in such patients. To date, data on infective endocarditis after TAVR have been limited to case reports and relatively small series with limited follow-up,3,4,7-10 demonstrating in-hospital complication and mortality rates as high as 87% and 47%, respectively. Valve explantation rates in such patients remain relatively low (<10%). It is therefore relevant to further investigate the factors associated with and the clinical characteristics and outcomes of infective endocarditis after TAVR.

1 September 2006 in The American Journal of Cardiology
Verified
Journal Article
Closed access
CECesar A. Esteves
Cesar A. Esteves
JMJuan S. Munoz
Juan S. Munoz
SBSergio Braga
Sergio Braga
JAJanuario Andrade
Januario Andrade
ZMZilda Meneghelo
Zilda Meneghelo
IPIgor F. Palacios
Igor F. Palacios

1 November 2019 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
ARAnder Regueiro
Ander Regueiro
ALAxel Linke
Axel Linke
Azeem LatibAzeem Latib
Azeem Latib
NINikolaj Ihlemann
Nikolaj Ihlemann
MUMarina Urena
Marina Urena
JRJosep Rodés-Cabau
Josep Rodés-Cabau
Background: No data exist about the characteristics of infective endocarditis (IE) post-transcatheter aortic valve replacement (TAVR) according to transcatheter valve type. We aimed to determine the incidence, clinical characteristics, and outcomes of patients with IE post-TAVR treated with balloon-expandable valve (BEV) versus self-expanding valve (SEV) systems. Methods: Data from the multicenter Infectious Endocarditis After TAVR International Registry was used to compare IE patients with BEV versus SEV. Results: A total of 245 patients with IE post-TAVR were included (SEV, 47%; BEV, 53%). The timing between TAVR and IE was similar between groups (SEV, 5.5 [1.2–15] months versus BEV, 5.3 [1.7–11.4] months; P =0.89). Enterococcal IE was more frequent in the SEV group (36.5% versus 15.4%; P <0.01), and vegetation location differed according to valve type (stent frame, SEV, 18.6%; BEV, 6.9%; P =0.01; valve leaflet, SEV, 23.9%; BEV, 38.5%; P =0.01). BEV recipients had a higher rate of stroke/systemic embolism (20.0% versus 8.7%, adjusted OR: 2.46, 95% CI: 1.04–5.82, P =0.04). Surgical explant of the transcatheter valve (SEV, 8.7%; BEV, 13.8%; P =0.21), and in-hospital death at the time of IE episode (SEV, 35.6%; BEV, 37.7%; P =0.74) were similar between groups. After a mean follow-up of 13±12 months, 59.1% and 54.6% of the SEV and BEV recipients, respectively, had died ( P =0.66). Conclusions: The characteristics of IE post-TAVR, including microorganism type, vegetation location, and embolic complications but not early or late mortality, differed according to valve type. These results may help to guide the diagnosis and management of IE and inform future research studies in the field.

10 January 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
VEVinicius Esteves
Vinicius Esteves
MOMarco A. P. Oliveira
Marco A. P. Oliveira
FFFernanda S. Feitosa
Fernanda S. Feitosa
JMJosé Mariani
José Mariani
CCCarlos M. Campos
Carlos M. Campos
PNPedro A. Lemos Neto
Pedro A. Lemos Neto

1 October 2012 in American Heart Journal
Verified
Journal Article
Closed access
PAPedro Beraldo de Andrade
Pedro Beraldo de Andrade
MTMarden André Tebet
Marden André Tebet
ENEderlon Ferreira Nogueira
Ederlon Ferreira Nogueira
VEVinícius Cardozo Esteves
Vinícius Cardozo Esteves
MAMônica Vieira Athanazio de Andrade
Mônica Vieira Athanazio de Andrade
LMLuiz Alberto Piva e Mattos
Luiz Alberto Piva e Mattos

24 June 2010 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
FMFelipe Maia
Felipe Maia
JCJ. Ribamar Costa
J. Ribamar Costa
AAAlexandre Abizaid
Alexandre Abizaid
FFFausto Feres
Fausto Feres
RCRicardo Costa
Ricardo Costa
JSJ. Eduardo Sousa
J. Eduardo Sousa